These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33927556)

  • 1. Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia.
    Lenicek Krleza J; Zrinski Topic R; Stevanovic V; Lukic-Grlic A; Tabain I; Misak Z; Roic G; Kaic B; Mayer D; Hruskar Z; Barbic L; Vilibic-Cavlek T
    Biochem Med (Zagreb); 2021 Jun; 31(2):020706. PubMed ID: 33927556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emergence of SARS-CoV-2 within the Dog Population in Croatia: Host Factors and Clinical Outcome.
    Stevanovic V; Tabain I; Vilibic-Cavlek T; Mauric Maljkovic M; Benvin I; Hruskar Z; Kovac S; Smit I; Miletic G; Hadina S; Staresina V; Radin L; Plichta V; Skrlin B; Vrbanac Z; Brkljacic M; Cvetnic M; Habus J; Martinkovic K; Zecevic I; Jurkic G; Ferencak I; Stritof Z; Perharic M; Bucic L; Barbic L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of SARS-CoV-2 Serology and Clinical Phenotype Amongst Hospitalised Children in a Tertiary Children's Hospital in India.
    Venkataraman A; Balasubramanian S; Putilibai S; Lakshan Raj S; Amperayani S; Senthilnathan S; Manoharan A; Sophi A; Amutha R; Sadasivam K; Goenka A; Ramanan AV
    J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33693892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
    Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
    JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
    Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
    JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
    Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA.
    Thomas SN; Altawallbeh G; Zaun CP; Pape KA; Peters JM; Titcombe PJ; Dileepan T; Rapp MJ; Bold TD; Schacker TW; Arbefeville S; Ferrieri P; Thyagarajan B; Jenkins MK; Karger AB
    Clin Biochem; 2021 Apr; 90():15-22. PubMed ID: 33539808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study.
    Szépfalusi Z; Schmidthaler K; Sieber J; Kopanja S; Götzinger F; Schoof A; Hoz J; Willinger B; Makristathis A; Weseslindtner L; Stiasny K; Bohle B; Krotka P; Graf A; Frischer T
    Pediatr Allergy Immunol; 2021 May; 32(4):762-770. PubMed ID: 33512035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA.
    Smith BK; Janowski AB; Danis JE; Harvey IB; Zhao H; Dai YN; Farnsworth CW; Gronowski AM; Roper S; Fremont DH; Wang D
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study.
    Lee J; Choe YJ; Minn D; Kim JH
    J Korean Med Sci; 2022 Nov; 37(44):e314. PubMed ID: 36377292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.
    Dimopoulou D; Kyritsi M; Dadouli K; Vergadi E; Tsiligianni E; Papadimitriou E; Mavridi A; Giannakopoulos S; Tsiourvopoulou G; Palyvou M; Angeli E; Brikos N; Eleftheriou I; Spoulou V; Michos A; Gkentzi D; Siomou E; Papaevangelou V; Grivea I; Syrogiannopoulos G; Galanakis E; Hadjichristodoulou C; Tsolia M
    Eur J Pediatr; 2023 Jan; 182(1):439-449. PubMed ID: 36383284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of SARS-CoV-2 antibodies in pediatric patients: An Iranian referral hospital-based study.
    Mamishi S; Esslami GG; Mohammadi M; Abdolsalehi MR; Sadeghi RH; Mahmoudi S; Pourakbari B
    Hum Antibodies; 2021; 29(3):217-223. PubMed ID: 34151783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA.
    Dileepan M; Di D; Huang Q; Ahmed S; Heinrich D; Ly H; Liang Y
    Virulence; 2021 Dec; 12(1):1597-1609. PubMed ID: 34125647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.
    Gelanew T; Seyoum B; Mulu A; Mihret A; Abebe M; Wassie L; Gelaw B; Sorsa A; Merid Y; Muchie Y; Teklemariam Z; Tesfaye B; Osman M; Jebessa G; Atinafu A; Hailu T; Habte A; Kenea D; Gadisa A; Admasu D; Tesfaye E; Bates TA; Bulcha JT; Tschopp R; Tsehay D; Mullholand K; Howe R; Genetu A; Tafesse FG; Abdissa A
    BMC Infect Dis; 2022 Mar; 22(1):261. PubMed ID: 35296265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.
    Shields A; Faustini SE; Perez-Toledo M; Jossi S; Aldera E; Allen JD; Al-Taei S; Backhouse C; Bosworth A; Dunbar LA; Ebanks D; Emmanuel B; Garvey M; Gray J; Kidd IM; McGinnell G; McLoughlin DE; Morley G; O'Neill J; Papakonstantinou D; Pickles O; Poxon C; Richter M; Walker EM; Wanigasooriya K; Watanabe Y; Whalley C; Zielinska AE; Crispin M; Wraith DC; Beggs AD; Cunningham AF; Drayson MT; Richter AG
    Thorax; 2020 Dec; 75(12):1089-1094. PubMed ID: 32917840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.